Nov. 7, 2022 – For the first time, laboratory-grown red blood cells have been transfused into human recipients, potentially paving the way for groundbreaking treatments for people with rare blood types or those with blood disorders such as sickle cell disease.
The red blood cells were grown from stem cells from donors. The trial is designed to compare the lifespan of the lab-grown cells with the lifespan of standard red blood cells from the same donor. At least eight more participants will each receive two “mini” transfusions – one transfusion of traditional red blood cells and one of the lab-grown cells. The two transfusions are given 4 months apart.
Amazing!♥️🧬
It's amazing great innovative medical step.
😄The medical field couldn’t get people to trust them less even if they tried at this point.people WOULDNT trust them anymore to do a mouth swab!!
Psychos